Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel via Pecs blocks in breast reconstruction
NCT05171179Phase 3Completed
- Sponsor
- Northwestern University
- Start
- Oct 2021
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of bupivacaine in postoperative pain, sponsored by Northwestern University. Primary endpoint: Opioid consumption at 2 weeks. Started Oct 2021; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05171179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05171179.